Pregnancy related breast cancer: report of three cases

Authors

  • Zaineb Chatbi Department of Obstetrics and Gynecology, Mohammed VI University Hospital, Oujda, Morocco
  • Saloua Sarsar Department of Obstetrics and Gynecology, Mohammed VI University Hospital, Oujda, Morocco
  • Hafsa Taheri Department of Obstetrics and Gynecology, Mohammed VI University Hospital, Oujda, Morocco
  • Hanane Saadi Department of Obstetrics and Gynecology, Mohammed VI University Hospital, Oujda, Morocco
  • Ahmed Mimoni Department of Obstetrics and Gynecology, Mohammed VI University Hospital, Oujda, Morocco

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20211157

Keywords:

Pregnancy-related breast cancer, Obstetrical outcome, Breast cancer

Abstract

Pregnancy-related breast cancer is defined as breast cancer diagnosed during pregnancy or within a year after delivery. In current report, 3 cases of breast cancer, diagnosed during pregnancy are presented. Different diagnostic challenges, different therapeutic methods and major influences of breast cancer on obstetrical outcomes are also discussed in current report. In current case series, the three patients had ages of 36, 40 and 44 years old. They were all diagnosed as having breast cancer during pregnancy. Diagnosis was achieved using imaging, and histopathology through breast biopsy. The histological type was not otherwise specified breast cancer in all three cases. Delivery was vaginal in two cases and through caesarean section in one case. Interruption of pregnancy was performed in one case. A bad prognosis was observed in one patient with death after chemotherapy and surgery, and a favourable evolution was observed in the two other cases. The management of this complex entity must be multidisciplinary.

References

Pavlidis N, Pentheroudakis G. The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev. 2005;31:439-47.

Klotz HA. Ueber mastitis carcinomatosa gravidarum et lactantium, Diss Halle-Wittenberg 1869. Available at: http://opacplus.bsb-muenchen.de/title/BV0135-45266/ft/bsb10856478?page=3. Accessed on 20 December 2020.

Knabben L, Mueller MD. Breast cancer and pregnancy. Hormone molecular biology and clinical investigation. De Gruyter. 2017;32(1):1.

Stensheim H, Moller B, van Dijk T, Fossa SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol. 2009;27:45-51.

Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994; 331:5-9.

Albrektsen G, Heuch I, Hansen S, Kvale G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer. 2005;92:167-75.

Bonnier P, Romain S, Dilhuydy JM. Influence of pregnancy on the outcome of breast cancer: a caseecontrol study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer. 1997;72:720-7.

Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005;23:4192-7.

Elledge RM, Ciocca DR, Langone G, McGuire WL. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients. Cancer 1993;71:2499-506.

Mielke S, Meden H, Kuhn W. Expression of the c-erbB-2-encoded oncoprotein p185 (HER-2/neu) in pregnancy as a model for oncogene-induced carcinogenesis. Med Hypotheses. 1998;50:359-62.

Saber A, Dardik H, Ibrahim IM, Wolodiger F. The milk rejection sign: a natural tumor marker. Am Surg. 1996;62:998-9.

Novotny DB, Maygarden SJ, Shermer RW, Frable WJ. Fine needle aspiration of benign and malignant breast masses associated with pregnancy. Acta Cytol. 1991;35:676-86.

Petrek JA. Breast cancer during pregnancy. Cancer. 1994;74(Suppl 1):518-27.

Downloads

Published

2021-03-24

Issue

Section

Case Series